TrialWorld journal of gastroenterology2023

Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial.

Yi-Xing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.